Dara Jospé

At Long Last: The New PMPRB Guidelines Are Here

CDA Opens Public Consultation On Pharmacare National Formulary – Deadline July 18, 2025

Health Canada's New Draft Guidance For Biosimilar Biologic Drugs

Bill 83 And Its Implications On Québec's Physicians And Health Care System

Bill 83 And Its Implications On Québec's Physicians And Health Care System

Pre-Market Considerations For Machine Learning-Enabled Medical Devices

New Guidance On "Made In Canada" Claims

Proposed Regulations To Mitigate Drug And Device Shortages In Canada

Federal Minister Of Health Issues Letter About Canada Health Act

Federal Court Of Appeal Rules That PMPRB Has No Jurisdiction Over Unpatented Medicine Prices: The End Of The "Slender Thread" Test